Kerala Ayurveda is currently trading at Rs. 60.80, up by 4.00 points or 7.04% from its previous closing of Rs. 56.80 on the BSE.
The scrip opened at Rs. 58.45 and has touched a high and low of Rs. 60.95 and Rs. 57.15 respectively. So far 1368 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 120.90 on 30-Nov-2017 and a 52 week low of Rs. 55.15 on 08-Oct-2018.
Last one week high and low of the scrip stood at Rs. 67.00 and Rs. 55.15 respectively. The current market cap of the company is Rs. 64.18 crore.
The promoters holding in the company stood at 61.52%, while Institutions and Non-Institutions held 0.05% and 38.43% respectively.
Kerala Ayurveda has signed a Joint Venture (JV) Agreement with Sanghvi Brands to develop Ayurvedagram Wellness Resorts and Ayurvedagram inspired Ayurvedic Spas across the world. The company and Sanghvi Brands each shall hold 50% of the paid-up share capital of the JV Company.
The joint venture will leverage the unparalleled Ayurveda expertise and credibility of Kerala Ayurveda, along with the global reach and operational infrastructure of Sanghvi Brands.
The joint venture will develop and operate Ayurvedagram Wellness Resorts varying in size from 30 keys to 100 keys. The joint venture will also develop Ayurvedic Wellness Spas inspired by Ayurvedagram, which would be made part of the Spas across luxury hotels, globally.
Kerala Ayurveda is a full spectrum-Listed Ayurveda company and a pioneer in propagating the rich heritage of Ayurveda. Its footprint spans Academies, Wellness Resorts, Hospitals, Clinics, Products and Services in India & USA.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: